Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 13:53 ET | Source: Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research Expands Board of Directors with Leaders to Help Accelerate Sarcoidosis Research, Advocacy and Patient Support

FSR announces the appointment of four new members to its Board of Directors.
May 07, 2025 16:01 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update

aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update
April 30, 2025 15:27 ET | Source: Foundation for Sarcoidosis Research

FSR Celebrates Congressional Recognition of April as Sarcoidosis Awareness Month

CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) today celebrated the official recognition of April as Sarcoidosis Awareness Month in the U.S. House of...
April 02, 2025 07:54 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Joins with Walgreens, Cedars-Sinai to Provide Foothill Unity with Free N95 Masks to Protect Residence Cleaning Up from the Recent Los Angeles Wildfires

Foundation for Sarcoidosis Research joins with Walgreens, Cedars-Sinai, and Foothill Unity to provide LA area free N95 masks to protect lung health.
March 26, 2025 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise

aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
March 12, 2025 16:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine

aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
February 03, 2025 11:30 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis

FSR increases funding to support sarcoidosis research
January 29, 2025 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference

Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline data from the study expected in the third quarter of 2025...
January 16, 2025 18:43 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences

Foundation for Sarcoidosis Research issues urgent public health alert in response to California wildfires, emphasizing heightened risk of sarcoidosis.
November 27, 2024 13:51 ET | Source: Foundation for Sarcoidosis Research

FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs

FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs

Next Page keyboard_arrow_right